Sign up Australia
Proactive Investors - Run By Investors For Investors

Lifespot Health eyes medicinal cannabis opportunities

To develop technologies to monitor medicinal cannabis use in patients.
Lifespot Health eyes medicinal cannabis opportunities
Lifespot was admitted to the ASX in January 2017

Lifespot Health’s (ASX:LSH) German subsidiary BodyTel is exploring global opportunities within the medicinal cannabis sector to integrate the BodyTel telemedical platform.

The company will explore opportunities to use its medical diagnostic and monitoring technologies to assist in the administration and monitoring of medicinal cannabis use in patients.

Lifespot is in discussions with a number of European-based medical device companies.

Last month, BodyTel signed an agreement with Beurer GmbH to integrate Beurer’s blood pressure monitoring device with BodyTel’s telemedical platform.

Beurer produces circa 2,200 products including weighing scales and blood pressure monitors, with a revenue of about €230 million.

BodyTel will build apps for patients based on Beurer`s newly developed bluetooth enabled clinical blood pressure monitoring device.

Lifespot was admitted to the ASX in January 2017 after raising $8 million at an issue price of $0.20 per share.

The company’s shares are presently trading 45% higher from its issue price, at $0.29.

Lifespot is rolling out its medical diagnostic and telemonitoring technologies into global markets, primarily the European and Australian markets.



Register here to be notified of future . Company articles
View full . profile

Proactive Investors Australia Timeline

Related Articles

learning symbol on a keyboard
January 17 2017
The English language learning specialist is confident it can kick on in the coming year
social-media.jpg
February 21 2017
One particular development of note is Cello Pulsar, a social media analytics tool that has, according to the experts, the potential to be a real winner.
White board with marketing ideas
March 14 2017
There was a bit of a wobble in the run-up to the Brexit vote and shortly after it, but the group's 'buy, build & grow' strategy is taking shape

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use